Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
about
Adjuvant therapy for resected pancreatic cancerAdjuvant chemotherapy for resected early-stage non-small cell lung cancerChemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancerRole of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new dataPost-operative radiation therapyMediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: a systematic review and meta-analysis2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancerPreoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data50 Years of progress in the systemic therapy of non-small cell lung cancerThe expression of four genes as a prognostic classifier for stage I lung adenocarcinoma in 12 independent cohortsSignificance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.A pooled exploratory analysis of the effect of tumor size and KRAS mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancerERCC1 isoform expression and DNA repair in non-small-cell lung cancer.Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data.Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study.Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data.Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy.Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study.Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma.Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer.Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapyCombining Carcinoembryonic Antigen and Platelet to Lymphocyte Ratio to Predict Brain Metastasis of Resected Lung Adenocarcinoma PatientsPropensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results databaseAdvances in adjuvant systemic therapy for non-small-cell lung cancer.Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma.Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis.Biomarkers in early-stage non-small-cell lung cancer: current concepts and future directions.Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.Benefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patients.Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study.Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.How close are we to customizing chemotherapy in early non-small cell lung cancer?Opportunistic illnesses in Brazilian children with AIDS: results from two national cohort studies, 1983-2007.C-reactive protein as a prognostic factor for human osteosarcoma: a meta-analysis and literature review.Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers.Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC).Update in lung cancer and oncological disorders 2010The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
P2860
Q24186323-FD5E7543-C726-4F9E-9B6A-B9ABDDB05614Q24187439-2ACC095E-BB0F-4FEE-8C92-AC22A2F690ABQ24235422-B7C71996-5397-45E5-853F-7CBE3B70ECF4Q24633254-B83BFFEA-130B-45AA-81CF-F5F101E57543Q26830376-8FDE672D-D312-40C3-BD4E-0B2B0FCDC154Q26859343-5CB8C0DE-A72D-4FD6-A7FE-157DF26370D4Q27002509-30573FA9-8702-4834-B72F-FB30AD772069Q27010262-D6ED1DE5-F7FD-4545-AE71-0DA6D8557A1CQ27014978-ED61F66D-1CFF-41EE-953D-E34374A14CD5Q28383695-5F264037-7F5B-419B-B09D-12FCD89019C0Q30358684-564A30EF-E703-423E-A6A7-F8EB5F7B2DDCQ30539299-35FCFBC7-614B-476D-B8E2-EB61CFD6F875Q30580553-D1EDC7BB-0EF8-478F-8529-0D6AC3DAC5CBQ30627447-E9110B42-B0B4-4CA9-918B-3E22C17353E9Q30868582-49FCB57B-B6D6-446D-BA94-78FD101C27E9Q30890572-885A16FF-33F9-42F7-9C98-18405374BBBAQ30906124-5F31DFF4-8520-4E58-B0D3-B0DBA8B0591AQ30976026-DAAD441A-E12D-441F-A60D-E59639AAB6C7Q30993385-4C71E11E-CF18-4A99-8978-65231ACE4615Q33404434-BBB10488-E9DC-415A-B5ED-672020B86B7DQ33684103-6A64307B-4AC5-4089-8EF1-A10DDAF0B09FQ33698439-29F91EA9-884C-4607-BF22-9A1992EED6FFQ33706852-F814BEBF-5109-4432-864E-F20967190925Q33794912-CA418E4E-03FB-4347-AFE3-EEAF26454B45Q33796191-0582D1D5-04FC-40F2-83BD-873EB3297561Q34031225-0103799F-B03F-4A7A-A8F0-C85A68CE08DAQ34165233-4B31FCB2-EA15-4DE2-93F5-EBCF4581DB97Q34479081-D504428F-0BCF-4433-AD08-8DF21491349CQ34623884-B8264EDD-B3CC-49D2-9B43-79722B9E9C43Q34957141-5F2E5DE9-C863-43FE-9B0F-C21ABEEA5996Q34978347-6E6125B0-7E4B-48EF-841D-B44270B32F80Q35104573-5EC1E309-100A-4FB1-8775-6FE276159D61Q35111780-9D227F6A-F7F5-44FF-84ED-E560EC5F73C7Q35146944-300A88E0-7B11-40BA-AF2A-472D7B7DABEAQ35147409-B55ED45E-49AC-43FB-BBB7-652798248A53Q35163616-C1AABCF0-583A-4FBB-A847-71A859704B9EQ35200656-777EBBC1-E15F-4D93-A604-045AD93691D2Q35200660-B01DAB94-0930-4C1D-BC9E-BE1A3D0B3260Q35219727-C791A561-06EF-428A-9A82-9020CA3F44B3Q35584147-7011AD56-3658-423E-999B-6FCC9DABF021
P2860
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Adjuvant chemotherapy, with or ...... ses of individual patient data
@ast
Adjuvant chemotherapy, with or ...... ses of individual patient data
@en
Adjuvant chemotherapy, with or ...... es of individual patient data.
@nl
type
label
Adjuvant chemotherapy, with or ...... ses of individual patient data
@ast
Adjuvant chemotherapy, with or ...... ses of individual patient data
@en
Adjuvant chemotherapy, with or ...... es of individual patient data.
@nl
prefLabel
Adjuvant chemotherapy, with or ...... ses of individual patient data
@ast
Adjuvant chemotherapy, with or ...... ses of individual patient data
@en
Adjuvant chemotherapy, with or ...... es of individual patient data.
@nl
P2093
P2860
P921
P1433
P1476
Adjuvant chemotherapy, with or ...... ses of individual patient data
@en
P2093
C Le Pechoux
D H Johnson
H Tribodet
J F Tierney
J P Higgins
J P Pignon
J van Meerbeeck
L A Stewart
M K B Parmar
P2860
P304
P356
10.1016/S0140-6736(10)60059-1
P407
P577
2010-03-24T00:00:00Z